Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 9.15a

Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year,

3 Years, 5 Years and 10 Years

Deceased Donor Liver Transplants

  3 Months 1 Year 3 Years 5 Years 10 Years
Surv. Std. Err. Surv. Std. Err. Surv. Std. Err. Surv. Std. Err. Surv. Std. Err.
Transplant Year # Transplants 77.5% 2.5% 66.9% 2.8% 61.5% 2.9% 57.5% 3.0% 46.9% 3.0%
1987 275
1988 1,421 83.1% 1.0% 75.8% 1.1% 68.2% 1.2% 64.3% 1.3% 54.3% 1.3%
1989 1,777 83.5% 0.9% 75.9% 1.0% 69.1% 1.1% 64.5% 1.1% 52.8% 1.2%
1990 2,221 86.2% 0.7% 78.7% 0.9% 71.5% 1.0% 66.8% 1.0% 55.3% 1.1%
1991 2,503 85.8% 0.7% 79.2% 0.8% 71.8% 0.9% 66.4% 0.9% 54.3% 1.0%
1992 2,584 87.0% 0.7% 80.5% 0.8% 73.3% 0.9% 67.8% 0.9% 54.3% 1.0%
1993 2,951 88.1% 0.6% 82.2% 0.7% 75.4% 0.8% 70.2% 0.8% 56.1% 0.9%
1994 3,091 90.0% 0.5% 84.4% 0.7% 77.9% 0.7% 73.0% 0.8% 59.3% 0.9%
1995 3,382 90.0% 0.5% 84.2% 0.6% 77.4% 0.7% 72.2% 0.8% 58.7% 0.8%
1996 3,445 89.5% 0.5% 84.1% 0.6% 77.5% 0.7% 71.7% 0.8% 57.8% 0.8%
1997 3,487 90.7% 0.5% 85.9% 0.6% 78.7% 0.7% 72.6% 0.8% 59.4% 0.8%
1998 3,856 90.8% 0.5% 85.9% 0.6% 78.4% 0.7% 72.5% 0.7% 59.4% 0.8%
1999 3,917 90.0% 0.5% 85.2% 0.6% 77.5% 0.7% 71.8% 0.7% 59.0% 0.8%
2000 3,950 91.5% 0.4% 86.7% 0.5% 79.4% 0.6% 73.9% 0.7% 61.1% 0.8%
2001 4,012 91.7% 0.4% 86.0% 0.5% 78.5% 0.6% 72.8% 0.7% + +
2002 4,266 92.8% 0.4% 87.0% 0.5% 78.9% 0.6% 73.9% 0.7% + +
2003 4,607 93.1% 0.4% 86.4% 0.5% 78.9% 0.6% 73.4% 0.7% + +
2004 5,007 93.2% 0.4% 87.1% 0.5% 78.3% 0.6% 72.5% 0.6% + +
2005 5,171 93.1% 0.4% 86.6% 0.5% 78.4% 0.6% 72.1% 0.7% + +
2006 5,351 94.2% 0.3% 87.5% 0.5% 79.7% 0.5% + + + +
2007 5,199 94.5% 0.3% 89.3% 0.4% 81.3% 0.6% + + + +
2008 5,170 94.6% 0.3% 88.5% 0.4% + + + + + +


Source: OPTN/SRTR Data as of October 1, 2010.

(+) = Values not determined due to insufficient follow-up.

Multi-organ transplants are excluded for kidney, pancreas, heart, lung, and liver survival rates.

Intestine survival includes intestine only and intestine with liver and/or pancreas transplants.

Living donor transplants excluded unless explicitly listed. Heterotopic heart and liver transplants excluded.

Patient survival follows patients from first transplant of this type until death. Graft survival follows individual transplants until graft

failure. Counts for patient and graft survival are different because a patient may have more than one transplant for a type organ.

See Technical Notes for complete discussion of patient and graft survival methods. See Technical Notes for details of patient and graft survival methods.